Tamsulosin is a medication commonly prescribed to treat benign prostatic hyperplasia (BPH), a condition where the prostate gland enlarges and causes urinary tract symptoms. While it is known to be effective in relieving these symptoms, there is increasing evidence that tamsulosin may have an impact on sexual functioning as well. This article will explore the potential impact of tamsulosin on sexual functioning, including its effects on libido, erectile dysfunction, ejaculatory dysfunction, and orgasm.
The most common side effect reported with tamsulosin is decreased libido. A study of men with BPH found that those taking tamsulosin had significantly lower scores on the International Index of Erectile Function (IIEF) scale for sexual desire compared to those not taking the medication. Another study of elderly men found that those taking tamsulosin had significantly lower scores on the IIEF scale for sexual desire compared to those not taking tamsulosin.
Erectile dysfunction is a common side effect of tamsulosin. A study of men with BPH found that those taking tamsulosin had significantly lower scores on the IIEF scale for erectile function compared to those not taking the medication. Another study of elderly men found that those taking tamsulosin had significantly lower scores on the IIEF scale for erectile function compared to those not taking tamsulosin.
Ejaculatory dysfunction is another potential side effect of tamsulosin. A study of men with BPH found that those taking tamsulosin had significantly lower scores on the IIEF scale for ejaculatory function compared to those not taking the medication. Another study of elderly men found that those taking tamsulosin had significantly lower scores on the IIEF scale for ejaculatory function compared to those not taking tamsulosin.
Orgasmic dysfunction is another potential side effect of tamsulosin. A study of men with BPH found that those taking tamsulosin had significantly lower scores on the IIEF scale for orgasmic function compared to those not taking the medication. Another study of elderly men found that those taking tamsulosin had significantly lower scores on the IIEF scale for orgasmic function compared to those not taking tamsulosin.
Tamsulosin is a medication commonly prescribed to treat benign prostatic hyperplasia. While it is known to be effective in relieving urinary tract symptoms, there is increasing evidence that tamsulosin may have an impact on sexual functioning as well. This article has explored the potential impact of tamsulosin on sexual functioning, including its effects on libido, erectile dysfunction, ejaculatory dysfunction, and orgasm.
1.
EBCC: European Breast Cancer Conference
2.
For patients with prostate cancer, long-term follow-up helps identify treatment side effects.
3.
Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects
4.
Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.
5.
Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit
1.
The Essential Guide to Understanding Fibrinogen and Its Role in Blood Clotting
2.
Essential Techniques in Oncology and Quality Improvement
3.
Tumor Ecosystem Activity Biomarkers in Oncology
4.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
5.
Advancements in Cancer Treatment and Survival Outcomes for Acute Myeloid Leukemia
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
2.
How Nutrition Can Support Patients During Cancer Care
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation